Clinical Trial Update: An Exploratory Study on the Use of Ivosidenib for the Precise Treatment of Advanced Biliary Tract Malignancies With IDH1 Mutations in the Later Line of Therapy. [Phase 2]

View source ↗

Summary

An exploratory Phase 2 study assessing the use of ivosidenib for IDH1-mutant biliary tract cancers in later lines of therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• Tibsovo (ivosidenib) (ivosidenib)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Biliary Tract Cancer | Phase 2 | Status: RECRUITING